Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11220)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2017 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Niu ZS, Niu XJ, Wang WH. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. World J Gastroenterol 2017; 23(32): 5860-5874 [PMID: 28932078 DOI: 10.3748/wjg.v23.i32.5860] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i32/5860.htm |
| Number | Citing Articles |
| 1 |
Weizheng Liang, Yan Zhao, Qingxue Meng, Wenjie Jiang, Shoulong Deng, Jun Xue. The role of long non-coding RNA in hepatocellular carcinoma. Aging 2024; 16(4): 4052 doi: 10.18632/aging.205523
|
| 2 |
Jianbing Wu, Xiaoxin Zhou, Yilei Fan, Xiangwei Cheng, Bin Lu, Zhe Chen. Long non-coding RNA 00312 downregulates cyclin B1 and inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo. Biochemical and Biophysical Research Communications 2018; 497(1): 173 doi: 10.1016/j.bbrc.2018.02.049
|
| 3 |
Ting Song, Li Li, Shaobo Wu, Yan Liu, Caiping Guo, Wen Wang, Lili Dai, Tong Zhang, Hao Wu, Bin Su. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.583714
|
| 4 |
Yingying Zhang, Hongyu Zhang, Shuhuan Wu. LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940. Journal of Hepatocellular Carcinoma 2021; : 333 doi: 10.2147/JHC.S306484
|
| 5 |
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
|
| 6 |
Shimaa E. Soliman, Abdel Monem A. ElTorgoman, Mohamed F.A. Assar, Naglaa S. El Abd, Suzy F. Gohar, Raouth E. Girgis. Biochemical and molecular study of long non-coding RNAs (HOTTIP, ZEB-AS1 and MEG-3) in hepatocellular carcinoma. Meta Gene 2020; 26: 100808 doi: 10.1016/j.mgene.2020.100808
|
| 7 |
Huojian Shen, Hongyi Zhu, Yuanwen Chen, Zhiyong Shen, Weiqing Qiu, Changlin Qian, Jie Zhang. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression. Cell Death & Disease 2021; 12(4) doi: 10.1038/s41419-021-03571-5
|
| 8 |
Harpreet Kaur, Sherry Bhalla, Gajendra P. S. Raghava, Ernest K. Amankwah. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. PLOS ONE 2019; 14(9): e0221476 doi: 10.1371/journal.pone.0221476
|
| 9 |
Liping Zhong, Xiuwen Zhong. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis. Bioengineered 2021; 12(1): 6629 doi: 10.1080/21655979.2021.1975019
|
| 10 |
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 2019; 204: 51 doi: 10.1016/j.trsl.2018.09.001
|
| 11 |
Wei Zhang, Songyang Liu, Kai Liu, Yahui Liu. Long non‐coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR‐133a to regulate IGF‐1R expression. Journal of Cellular and Molecular Medicine 2019; 23(8): 5154 doi: 10.1111/jcmm.14384
|
| 12 |
Ying Wu, Peng‐Shuo Wang, Ben‐Gang Wang, Lu Xu, Wan‐Xia Fang, Xiao‐Fang Che, Xiu‐Juan Qu, Yun‐Peng Liu, Zhi Li. Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma. Cancer Medicine 2018; 7(12): 6219 doi: 10.1002/cam4.1854
|
| 13 |
Wenjing Xiao, Dezhi Zheng, Xin Chen, Botao Yu, Kaiwen Deng, Jie Ma, Xudong Wen, Yonghe Hu, Jun Hou. Long non-coding RNA MIAT is involved in the regulation of pyroptosis in diabetic cardiomyopathy via targeting miR-214-3p. iScience 2021; 24(12): 103518 doi: 10.1016/j.isci.2021.103518
|
| 14 |
Hyun Jin Jung, Hyun-Ju Kim, Kwan-Kyu Park. Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis. International Journal of Molecular Sciences 2020; 21(8): 2698 doi: 10.3390/ijms21082698
|
| 15 |
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacological Research 2020; 160: 105195 doi: 10.1016/j.phrs.2020.105195
|
| 16 |
Tiago Falcon, Martiela Freitas, Ana Carolina Mello, Laura Coutinho, Mario R. Alvares-da-Silva, Ursula Matte. Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/2864120
|
| 17 |
Yan Lv, Yin Wang, Yu Song, Shu-Sheng Wang, Kai-wen Cheng, Zhi-qing Zhang, Jin Yao, Li-na Zhou, Zhuo-yan Ling, Cong Cao. LncRNA PINK1-AS promotes Gαi1-driven gastric cancer tumorigenesis by sponging microRNA-200a. Oncogene 2021; 40(22): 3826 doi: 10.1038/s41388-021-01812-7
|
| 18 |
Min Hao, Jinling Zan, Hafiz Ishfaq Ahmad. The Identification of Childhood Asthma Progression-Related lncRNAs and mRNAs Suitable as Biomarkers Using Weighted Gene Coexpression Network Analysis. Genetics Research 2021; 2021: 1 doi: 10.1155/2021/5511507
|
| 19 |
Shengwei Tao, Shuhang Liang, Taofei Zeng, Dalong Yin. Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1043667
|
| 20 |
Behnam Alipoor, Seyedeh Nasrin Parvar, Zolfaghar Sabati, Hamid Ghaedi, Hassan Ghasemi. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. Molecular Biology Reports 2020; 47(8): 6357 doi: 10.1007/s11033-020-05695-x
|
| 21 |
Maryam Farzaneh, Majid Ghasemian, Farhoodeh Ghaedrahmati, Jafar Poodineh, Sajad Najafi, Tariq Masoodi, Dedy Kurniawan, Shahab Uddin, Shirin Azizidoost. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma. Life Sciences 2022; 308: 120974 doi: 10.1016/j.lfs.2022.120974
|
| 22 |
Fang Guo, Yun-Zhi Chen, Liu Li, Cong Chen, Jian-Hua Jin, Jie Yang, Jing-Jing Chen, Xin-Yan Chen, Min Guo, Yu-Mei Chen. Long non-coding RNA XLOC_008466 acts as an oncogenic molecular in cervical cancer tumorigenesis. Biomedicine & Pharmacotherapy 2018; 98: 88 doi: 10.1016/j.biopha.2017.11.143
|
| 23 |
Zhanpeng Wang, Lina Song, Yanshuo Ye, Wei Li. <p>Long Noncoding RNA DIO3OS Hinders Cell Malignant Behaviors of Hepatocellular Carcinoma Cells Through the microRNA-328/Hhip Axis</p>. Cancer Management and Research 2020; : 3903 doi: 10.2147/CMAR.S245990
|
| 24 |
Fatemeh Davodabadi, Shekoufeh Mirinejad, Sumira Malik, Archna Dhasmana, Fulden Ulucan-Karnak, Sara Sargazi, Saman Sargazi, Sonia Fathi-Karkan, Abbas Rahdar. Nanotherapeutic approaches for delivery of long non-coding RNAs: an updated review with emphasis on cancer. Nanoscale 2024; 16(8): 3881 doi: 10.1039/D3NR05656B
|
| 25 |
Bin Wang, Xiangpan Li, Wenjuan Hu, Yu Zhou, Youming Din. Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization. IUBMB Life 2019; 71(12): 1952 doi: 10.1002/iub.2137
|
| 26 |
Young-Ah Kim, Kwan-Kyu Park, Sun-Jae Lee. LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(8): 2883 doi: 10.3390/ijms21082883
|
| 27 |
Yufeng Wang, Zhencun Yang, Liang Wang, Liankang Sun, Zhikui Liu, Qing Li, Bowen Yao, Tianxiang Chen, Cong Wang, Wei Yang, Qingguang Liu, Shaoshan Han. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomedicine & Pharmacotherapy 2019; 109: 991 doi: 10.1016/j.biopha.2018.10.145
|
| 28 |
Mohamed H. Yousef, Hassan A. N. El-Fawal, Anwar Abdelnaser, Junyan Tao. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9593254
|
| 29 |
Zhongju Shi, Bin Pan, Shiqing Feng. The emerging role of long non‐coding RNA in spinal cord injury. Journal of Cellular and Molecular Medicine 2018; 22(4): 2055 doi: 10.1111/jcmm.13515
|
| 30 |
Zichen Xie, Heng Zhang, Jiqin Wang, Zhimin Li, Chao Qiu, Keyu Sun. LIN28B-AS1-IGF2BP1 association is required for LPS-induced NFκB activation and pro-inflammatory responses in human macrophages and monocytes. Biochemical and Biophysical Research Communications 2019; 519(3): 525 doi: 10.1016/j.bbrc.2019.09.012
|
| 31 |
Edie-Rosmin Wu, Ying-Erh Chou, Yu-Fan Liu, Kuan-Chun Hsueh, Hsiang-Lin Lee, Shun-Fa Yang, Shih-Chi Su. Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma. Genes 2019; 10(7): 506 doi: 10.3390/genes10070506
|
| 32 |
Aiyao Wang, Jun Meng, Hui Liu, Chen Li, Zhiyong Zhou. Long non‑coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion. Oncology Letters 2020; 20(3): 2779 doi: 10.3892/ol.2020.11826
|
| 33 |
Yongping Zhou, Yonggang Huang, Tu Dai, Zhiyuan Hua, Jian Xu, Yuting Lin, Lulu Han, Xiong Yue, Lichen Ho, Jinjing Lu, Xiaoming Ai. LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging miR-16-5p and upregulation of cyclin E1. Biomedicine & Pharmacotherapy 2021; 133: 111030 doi: 10.1016/j.biopha.2020.111030
|
| 34 |
Yu Li, Gang Liu, Xiaojun Li, Huiyuan Dong, Weike Xiao, Shaokang Lu. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochemical and Biophysical Research Communications 2018; 503(4): 2826 doi: 10.1016/j.bbrc.2018.08.047
|
| 35 |
Le Lu, Yufan Wu, Min Feng, Xiaofeng Xue, Yuan Fan. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10665
|
| 36 |
Xiaohong Zhang, Jian Li, Fan Li, Zhen Zhao, Li Feng. LINC00682 inhibits gastric cancer cell progression via targeting microRNA-9-LMX1A signaling axis. Aging 2019; 11(23): 11358 doi: 10.18632/aging.102533
|
| 37 |
Li Feng, Huanqin Li, Fan Li, Songhua Bei, Xiaohong Zhang. LncRNA KCNQ1OT1 regulates microRNA-9-LMX1A expression and inhibits gastric cancer cell progression. Aging 2020; 12(1): 707 doi: 10.18632/aging.102651
|
| 38 |
Jian Zhang, Kewei Hu, Yong-qiang Yang, Yin Wang, Yu-fan Zheng, Yong Jin, Ping Li, Long Cheng. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression. Cell Death & Disease 2020; 11(9) doi: 10.1038/s41419-020-02967-z
|
| 39 |
Ge Yang, Yang Fu, Xiaoyan Lu, Menghua Wang, Hongtao Dong, Qiuming Li. LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells. Journal of Cellular and Molecular Medicine 2018; 22(10): 5083 doi: 10.1111/jcmm.13796
|
| 40 |
Kevin Park, Mysore S. Veena, Daniel Sanghoon Shin. Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.830208
|
| 41 |
Hao Wu, Tian Tian Liu, Yue Min Feng, Xiao Yu Xie, Xiao Nan Su, Jian Ni Qi, Qiang Zhu, Cheng Yong Qin. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus‐related hepatocellular carcinoma after hepatectomy. Journal of Digestive Diseases 2020; 21(11): 650 doi: 10.1111/1751-2980.12941
|
| 42 |
Guijun He, Wenfeng Yao, Liang Li, Yang Wu, Guojian Feng, Li Chen. LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01565-5
|
| 43 |
Jin-qian Liang, Zhen-tao Zhou, Lin Bo, Hai-ning Tan, Jian-hua Hu, Ming-sheng Tan. Phosphoglycerate kinase 1 silencing by a novel microRNA microRNA-4523 protects human osteoblasts from dexamethasone through activation of Nrf2 signaling cascade. Cell Death & Disease 2021; 12(11) doi: 10.1038/s41419-021-04250-1
|
| 44 |
Deyu Huang, Chunhua Bi, Qingxi Zhao, Xueli Ding, Cheng Bian, Hui Wang, Ting Wang, Hua Liu. RETRACTED ARTICLE: Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4831-6
|
| 45 |
Lee Jin Lim, Samuel Y.S. Wong, Feiyang Huang, Sheng Lim, Samuel S. Chong, London Lucien Ooi, Oi Lian Kon, Caroline G. Lee. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma. Cancer Research 2019; 79(20): 5131 doi: 10.1158/0008-5472.CAN-19-0255
|
| 46 |
Gao Liu, Zhang-Fu Yang, Jian Sun, Bao-Ye Sun, Pei-Yun Zhou, Cheng Zhou, Ruo-Yu Guan, Zhu-Tao Wang, Yong Yi, Shuang-Jian Qiu. The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. Cellular Oncology 2022; 45(6): 1435 doi: 10.1007/s13402-022-00730-4
|